Patient preference trials in oncology: a scoping review and recommendations on reporting
D. Kamp(Utrecht University), Rolf H. H. Groenwold(Leiden University Medical Center), Hanneke W.M. van Laarhoven(Dutch Cancer Society), Anne M. May(Utrecht University), Renée Schmitz(The Netherlands Cancer Institute), Nadia Haj Mohammad(Utrecht University), Joanna IntHout(Radboud University Nijmegen), Roy P. C. Kessels(Radboud University Nijmegen)
Cited by 1
Related Papers
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial
|The Lancet. Gastroenterology & hepatology|2019|597
Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial
|The Lancet Neurology|2019|579
Korsakoff’s syndrome: a critical review
|Neuropsychiatric Disease and Treatment|2017|261
White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
|Nature Communications|2020|238
ESMO Guidance for Reporting Oncology real-World evidence (GROW)
|Annals of Oncology|2023|209